A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup

Akira Kawai, Nobuaki Fukasawa, Taito Esaki et al.|Japanese Journal of Clinical Oncology|2016

Cited by 38